Galantamine: A Review of its Use in Alzheimer's Disease

Author： Scott L.J.   Goa K.L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.60, Iss.5, 2000-11, pp. : 1095-1122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease

By Lyseng-Williamson K.A.   Plosker G.L.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 919-942

Adis International

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David   Hampel Harald   Pantel Johannes  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: A Review of its Use in Alzheimer's Disease

By Spencer C.M.   Noble S.  

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 391-411

Adis International

Access to resources Recommend Favorite

Memantine: A Review of its Use in Alzheimer's Disease

By Robinson Dean M.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1515-1534

Adis International

Access to resources Recommend Favorite

Metrifonate: A Review of its Use in Alzheimer’s Disease

By Ormrod D.   Spencer C.  

CNS Drugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 443-467

Adis International

Access to resources Recommend Favorite